Insmed Incorporated
Trade Insmed Incorporated 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About INSM
Insmed, Inc. is a global biopharmaceutical company, which engages in the development and commercialization of therapies for patients with rare diseases. Its focuses on Brensocatib, and Treprostinil Palmitil Inhalation Powder (TPIP) pipeline.
INSM Key Statistics
Stock Snapshot
With a market cap of 31.01B, Insmed Incorporated(INSM) trades at $142.81. The stock has a price-to-earnings ratio of -50.19.
During the trading session on 2026-11-22, Insmed Incorporated(INSM) shares reached a daily high of $150.00 and a low of $140.99. At a current price of $142.81, the stock is +1.3% higher than the low and still -4.8% under the high.
Trading volume for Insmed Incorporated(INSM) stock has reached 6.22M, versus its average volume of 3.86M.
The stock's 52-week range extends from a low of $90.39 to a high of $212.75.
The stock's 52-week range extends from a low of $90.39 to a high of $212.75.
INSM News
Sanofi is reportedly exploring a potential acquisition of Insmed (NasdaqGS: INSM), according to market sources referenced on 20 November 2026. Discussions are...
French pharmaceutical giant Sanofi SA (NASDAQ:SNY) is reportedly exploring a potential acquisition of Insmed Inc. (NASDAQ:INSM). As per a Thursday Bloomberg re...
Insmed Inc. (NASDAQ:INSM) shares are rising. A report surfaced that Sanofi is exploring an offer for the rare-disease drug developer. Insmed stock is gaining p...
Analyst ratings
96%
of 25 ratingsMore INSM News
Insmed (INSM) may be worth $170-$210 a share in a takeover after a report that Sanofi (SNY) is weighing a purchase of the drugmaker, according to an RBC analyst...
After Bloomberg reported that Sanofi (SNY) is evaluating a potential acquisition of Insmed (INSM), BMO Capital analyst Conor MacKay argued that adding Insmed’s...
Insmed Inc. (NASDAQ:INSM) stock surged Thursday following a report that French pharmaceutical giant Sanofi SA (NASDAQ:SNY) is exploring a potential acquisition...
Insmed (INSM) announced an update on their ongoing clinical study. Study Overview: Insmed’s INSPIRE AT study, officially titled “INSPIRE AT: Longitudinal Study...
Sanofi (SNY) is exploring a potential acquisition of U.S. drugmaker Insmed (INSM), which could rank among the largest biopharma deals in recent years, Bloomberg...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.